Omnia: a special year

Omnia Holdings has bucked the trend this year in a big way. The share price is up over 15% at a time when the market has burned bright red. In a bear market, picking your stocks is important.

For the year ended March 2022, revenue increased by a juicy 30% and operating profit (excluding Zimbabwe) shot up by 123%. Headline earnings per share (HEPS) was 86% higher at 672 cents.

By all accounts, this was a strong year.

Omnia has made a song and dance about its cash and capital management and hasn’t been shy to pay large special dividends. This year, the ordinary dividend of 275 cents is 37.5% higher than the prior year’s ordinary dividend of 200 cents. The special dividend of 525 cents is 31.25% higher than the 400 cents special dividend in the prior year.

It’s not often that a company pays special dividends in consecutive years. Omnia has been rationalising its investment portfolio and has sold off certain parts of the group in both years. Some say there is more to come.

The cash position is 31% higher year-on-year, which is a growth rate that is similar to the increase in the overall dividend.

Agriculture segment

This segment contributed just over half of group revenue and operating profit.

Revenue was 41% higher and operating profit from continuing operations (the right way to view it vs. revenue) was 17% higher, so there has been a margin squeeze here. Omnia attributes this to higher operating costs (obviously) and a fixed-price contract in Zambia.

The company reminds us that results from Zimbabwe are subject to hyperinflationary earnings volatility. The group also operates in Australia and Brazil, both of which posted solid results.

Investors should remember that the drivers of this great revenue result (like a good crop harvest and higher commodity prices) are volatile by nature. Primary agriculture is a tough place to play and Omnia is directly exposed to this industry.

Mining

The mining segment contributed nearly a third of group revenue from continuing operations and just over a quarter of group operating profit. Revenue was up 29% and operating profit jumped by 79%, so margins went in the right direction here.

Revenue was driven by increased sales volumes and a higher ammonia price. Margins improved thanks to a focus on operational efficiencies, market expansion and larger contracts, which simply tells me that economies of scale are coming through in this segment.

There are important structural underpins to the result, like demand for specialist chemicals and services in the battery metals and PGM markets, both of which are really important going forward as the world focuses on emissions.

Still, Omnia is once again exposed to a cyclical industry here, so investors must be cautious when forecasting growth.

Chemicals

The chemicals segment contributed almost 15% of group revenue from continuing operations and nearly 9% of group operating profit. Revenue was up only 2% and operating profit jumped by 41%, so the revenue mix made all the difference here in improving margins and driving profit growth.

The balancing numbers

Those of you with a strong feel for the numbers might be thinking that these segments don’t add up to the group total. The balancing numbers relate to head office costs and discontinued operations, like Umongo Petroleum which Omnia sold during the financial year.

SARS audit

In case you thought everything was perfect at Omnia, think again. The group is dealing with a SARS audit related to its transfer pricing practices between 2014 and 2016. SARS has raised an additional assessment of R415 million and understatement penalties of R165 million. If that isn’t bad enough, there’s also an interest amount of R365 million.

So, that’s a fight with the tax authorities worth R945 million, which is a huge number. Operating profit for this financial year excluding Zimbabwe was R1,726 million, so this is a critical battle.

Omnia has raised an objection with SARS and the receiver has until 30 September 2022 to respond. In the meantime, a payment of R207 million was made to SARS in December 2021 and interest continues to accrue on the rest.

Omnia believes that the most probable outcome is an Alternative Dispute Resolution process.

Outlook

Omnia has been working hard to simplify the group and optimise supply chains and manufacturing capabilities. It’s great to enjoy the benefits of being at the right point in the cycle (e.g. in mining) but experienced hands are well aware that these conditions are usually here for a good time rather than a long time.

The group has done well in its core operations but it needs to resolve the SARS issue to give investors certainty around that matter.

My major irritation is that the short-form SENS announcement doesn’t mention the SARS problem and this isn’t the first time that Omnia has buried it deeper in the presentations and reports. You have to read the full results booklet to find information on it. This really isn’t good enough from a disclosure perspective and it gives a poor impression of the company’s attitude towards shareholders.

Leave a reply

Please enter your comment!
Please enter your name here

Latest Articles

Boring business billions

The world’s richest people aren’t always building apps or chasing disruption. Here are three stories that reveal how unglamorous industries keep minting billionaires. From billboards to pig farming and car mats, there are many ways to make it big.

Ghost Bites (AB InBev | Jubilee Metals | HCI | Schroder European Real Estate)

With all the news from the first week of January 2026 included in one Ghost Bites, you'll find deal news at AB InBev, Jubilee Metals and HCI. There's also a valuation update at Schroder European Real Estate.

Why ETFs Play a Vital Role in Private Markets

Exchange Traded Funds (ETFs) have emerged as a transformative solution, for public markets and also as a strategic bridge to private market exposure. The border between traditional and alternative asset management is dissolving. Clients are driving the convergence, seeking integrated solutions that blend public and private exposures. Duma Mxenge of Satrix explains.

Ghost Bites (AfroCentric | Aspen | Novus – Mustek)

Aspen announced the disposal of Aspen APAC and the market loved it. AfroCentric is disposing of Activo and the market forgot to notice - for now, at least. And for Novus, a purchase of 3,000 shares has turned out to be very expensive in the Mustek deal.

UNLOCK THE STOCK: Southern Sun

In the 65th edition of Unlock the Stock, Southern Sun joined the platform to talk about the recent numbers and the strategic outlook for the business.

Ghost Bites (Mr Price | NEPI Rockcastle)

Mr Price isn't backing off on the NKD deal, despite the absolute hatred for the transaction from the market. NEPI's pre-close update shows the importance of looking at per-share growth.

Sponsored

Ghost Stories #89: 25 years of Satrix – how indexation changed investing in South Africa

In the year 2000, a lot happened. There was some questionable pop music. There was also the Dot-Com Crisis, followed by a period that saw incredible equity returns in South Africa until the Global Financial Crisis hit in 2007/2008. And during that important period in our local market, we also saw the emergence and initial growth of ETFs in South Africa, spearheaded by Satrix. To reflect on 25 years of ETFs in South Africa, René Basson joined me to share the important milestones and fascinating stories that defined this journey. Join us as we look back on how Satrix made it possible for everyone to own the market.

The Finance Ghost Plugged in with Capitec: Ep 6 (Noodles without borders – bringing miso to Mzansi)

Lu-ise Hattingh and Ruan Botha are a great example of the power and value of travel. After spending time in Japan, they fell in love with the culture and food. As all great entrepreneurs do, they also took the opportunity to learn about the Japanese approach to consumer brands. That curiosity eventually sparked a business idea they brought back home. Today, Lu-ise and Ruan are rolling out Market Kokoro franchise stores in South Africa.

Ghost Stories #88: Cell C – more than just an MVNO engine

Cell C has been on quite the adventure in its efforts to carve out a sustainable competitive position. Cell C has created a profitable business model that goes well beyond the MVNO operations that the market tends to focus on. In this podcast, CEO Jorge Mendes joined me to explain Cell C's business and how they plan to win across key verticals.

Ghost Stories #87: Lessons from 2025 – discipline over drama

As we look back on a fascinating year in the markets, Nico Katzke (Head of Portfolio Solutions at Satrix) delivered a fantastic mix of insights on this podcast that can be applied to your strategy in 2026 and beyond. From being careful not to learn the wrong lessons through to choosing simplicity over complexity, there's a lot of great stuff in here to get you ready for another year in the markets.